Ironwood Pharmaceuticals reported $117.13M in Gross Profit on Sales for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US USD 128.58M 3.32M
Agios Pharmaceuticals AGIO:US USD 3M 2.15M
Akebia Therapeutics AKBA:US USD 19.28M 96.99M
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
Amarin AMRN:US USD 65.94M 7.31M
Astellas Pharma 4503:JP JPY 317.61B 24.69B
Astrazeneca AZN:US USD 8.86B 3M
AstraZeneca AZN:LN USD 8.86B 3M
Bluebird Bio BLUE:US USD 71K 297K
Charles River Laboratories CRL:US USD 370.22M 13.5M
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
Exact Sciences EXAS:US USD 375.14M 1.9M
Halozyme Therapeutics HALO:US USD 161.66M 43.24M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
Karyopharm Therapeutics KPTI:US USD 35.16M 3.58M
MacroGenics MGNX:US USD 38.59M 14.99M
Moderna Inc MRNA:US USD 2.26B 1.1B
Myriad Genetics MYGN:US USD 106M 23.6M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Takeda 4502:JP JPY 696.86B 17.28B
Ultragenyx Pharmaceutical RARE:US USD 82.07M 999K
YTE INCY:US USD 774.02M 92.14M